Richard Churchill is a Senior Associate Scientist II at Akouos, where Richard focuses on genetic delivery technologies for treating hearing loss and deafness. Prior to that, Richard worked as a Research Associate at Arkuda Therapeutics and a Sr. Research Associate at Lysosomal Therapeutics Inc., exploring treatments for neurodegenerative diseases. Richard also has experience in molecular biology, gene therapy, and lab management from their time at Brandeis University and other companies. Richard holds a Bachelor of Science in Cellular/Molecular Neuroscience from Trinity College-Hartford.
April 1, 2023 - present
July, 2021
December, 2019
June, 2019
Senior Associate Scientist II at Kelonia Therapeutics
Senior Associate Scientist II at Kelonia Therapeutics
Senior Associate Scientist II at Seismic Therapeutic
Senior Associate Scientist II at Seismic Therapeutic
Senior Associate Scientist II at Kelonia Therapeutics